When did Balchem report Q3 2024 earnings?

Balchem (BCPC) reported Q3 2024 earnings on October 25, 2024 before market open.

What were Balchem's Q3 2024 revenue and EPS?

Balchem reported revenue of $239.9M and eps of $1.13 for Q3 2024.

Did Balchem beat estimates in Q3 2024?

Revenue beat the consensus estimate of $235.1M by $4.9M. EPS beat the consensus estimate of $1.11 by $0.02.

Where can I find Balchem's Q3 2024 SEC filings?

You can read the 10-Q periodic report (0001628280-24-043795) directly on SEC EDGAR. The filing index links above go to sec.gov.

Balchem BCPC Q3 2024 earnings

Reported October 25, 2024 · Before market open

Revenue$239.9MBeat by $4.9M

EPS$1.13Beat by $0.02

Revenue estimate$235.1M

EPS estimate$1.11

Next report

Jul 31, 2026 (In 2 days)

Revenue estimate$268.5M

EPS estimate$1.27

Financials

Q3 2024

Income statement

See full

Revenue$239.9M+4.3%

Gross profit$85.4M+11.5%

Operating income$48.0M+10.0%

Net income$33.8M+16.4%

EPS (diluted)$1.03+14.4%

Balance sheet

See full

Cash & equivalents$73.7M-4.2%

Total debt$36.2M+5.1%

Total equity$1.2B+14.8%

Total assets$1.6B-0.4%

Cash flow

See full

Operating cash flow$51.3M+10.3%

Valuation & ratios

Valuation

as of 09/30/24

See full

Market cap$5.69B+42.7%

Enterprise value$5.65B+43.3%

P/E46.8×+8.2×

P/S6×+1.7×

Profitability

See full

Gross margin34.5%+2.5pp

Operating margin18.4%+1.8pp

Net margin12.9%+1.7pp

Returns & leverage

See full

Return on equity11%+0.3pp

Debt / equity0×0.0×

Current ratio3×-0.2×

Segments

By segment

See full

Human Nutrition and Health$152.3M+5.4%

Animal Nutrition and Health$52.9M-1.9%

Specialty Products$33.2M+10.6%

By product

See full

Product Sales Revenue$239.5M—

Royalty Revenue$418.0K—

By geography

See full

United States$182.0M—

Versus estimates

Revenue

Q1 2026$270.7MBeat by $4.2M Q4 2025$263.6MBeat by $4.0M Q2 2025$255.5MMiss by $2.2M Q1 2025$250.5MBeat by $4.8M Q4 2024$240.0MMiss by $4.9M

Q3 2024$239.9MBeat by $4.9M

Diluted EPS

Q1 2026$1.25Miss by $0.16 Q4 2025$1.31Beat by $0.02 Q2 2025$1.27Beat by $0.02 Q1 2025$1.22Miss by $0.03 Q4 2024$1.03Miss by $0.08

Q3 2024$1.13Beat by $0.02

Ask the moment Balchem reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Balchem report Q3 2024 earnings?: Balchem (BCPC) reported Q3 2024 earnings on October 25, 2024 before market open.
What were Balchem's Q3 2024 revenue and EPS?: Balchem reported revenue of $239.9M and eps of $1.13 for Q3 2024.
Did Balchem beat estimates in Q3 2024?: Revenue beat the consensus estimate of $235.1M by $4.9M. EPS beat the consensus estimate of $1.11 by $0.02.
Where can I find Balchem's Q3 2024 SEC filings?: You can read the 10-Q periodic report (0001628280-24-043795) directly on SEC EDGAR. The filing index links above go to sec.gov.